ALA and heart risk
This article was originally published in The Tan Sheet
Executive Summary
Women on diets rich in alpha-linolenic acid (ALA) demonstrate a lower risk of heart disease and heart attacks than women on diets with lower concentrations of the fatty acid, Christine Albert, MD, Harvard University Medical School, et al., assert at the AHA meeting Nov. 8. The group conducted an observational study included 76,763 women who completed a questionnaire in 1984 as part of the Nurse's Health Study; subjects in the highest ALA intake group demonstrated a 46% reduced risk of death from cardiac death and a 21% reduced risk of death from coronary heart disease. Further studies are needed to fully assess impact of ALA on heart risk...
You may also be interested in...
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.